| Absorption |
| Blood-Brain Barrier | BBB+ | 0.7113 |
| Human Intestinal Absorption | HIA- | 0.8442 |
| Caco-2 Permeability | Caco2- | 0.8957 |
| P-glycoprotein Substrate | Non-substrate | 0.5759 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.7598 |
| Non-inhibitor | 0.8400 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.7480 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7796 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8470 |
| CYP450 2D6 Substrate | Non-substrate | 0.8591 |
| CYP450 3A4 Substrate | Non-substrate | 0.6168 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9418 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9095 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9278 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8373 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9410 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8369 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9653 |
| Non-inhibitor | 0.7675 |
| AMES Toxicity | Non AMES toxic | 0.9202 |
| Carcinogens | Non-carcinogens | 0.9565 |
| Fish Toxicity | Low FHMT | 0.5550 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.7324 |
| Honey Bee Toxicity | High HBT | 0.7212 |
| Biodegradation | Not ready biodegradable | 0.9116 |
| Acute Oral Toxicity | IV | 0.5888 |
| Carcinogenicity (Three-class) | Non-required | 0.6497 |